These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32154238)

  • 1. Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation.
    Zhao N; Yang X; Calvelli HR; Cao Y; Francis NL; Chmielowski RA; Joseph LB; Pang ZP; Uhrich KE; Baum J; Moghe PV
    Front Bioeng Biotechnol; 2020; 8():112. PubMed ID: 32154238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.
    Bennett NK; Chmielowski R; Abdelhamid DS; Faig JJ; Francis N; Baum J; Pang ZP; Uhrich KE; Moghe PV
    Biomaterials; 2016 Dec; 111():179-189. PubMed ID: 27736702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
    Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
    J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss.
    Ho DH; Nam D; Seo M; Park SW; Seol W; Son I
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
    Saramowicz K; Siwecka N; Galita G; Kucharska-Lusina A; Rozpędek-Kamińska W; Majsterek I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).
    Lei Q; Wu T; Wu J; Hu X; Guan Y; Wang Y; Yan J; Shi G
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.
    Hinkle JT; Patel J; Panicker N; Karuppagounder SS; Biswas D; Belingon B; Chen R; Brahmachari S; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118819119. PubMed ID: 35394877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model.
    Villadiego J; Labrador-Garrido A; Franco JM; Leal-Lasarte M; De Genst EJ; Dobson CM; Pozo D; Toledo-Aral JJ; Roodveldt C
    Glia; 2018 Jan; 66(1):191-205. PubMed ID: 29024008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
    Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model.
    Thi Lai T; Kim YE; Nguyen LTN; Thi Nguyen T; Kwak IH; Richter F; Kim YJ; Ma HI
    NPJ Parkinsons Dis; 2024 Feb; 10(1):32. PubMed ID: 38302446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.
    Santa-Cecília FV; Socias B; Ouidja MO; Sepulveda-Diaz JE; Acuña L; Silva RL; Michel PP; Del-Bel E; Cunha TM; Raisman-Vozari R
    Neurotox Res; 2016 May; 29(4):447-59. PubMed ID: 26745968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.
    Roodveldt C; Labrador-Garrido A; Gonzalez-Rey E; Lachaud CC; Guilliams T; Fernandez-Montesinos R; Benitez-Rondan A; Robledo G; Hmadcha A; Delgado M; Dobson CM; Pozo D
    PLoS One; 2013; 8(11):e79160. PubMed ID: 24236103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neuroinflammatory effects of tannic acid against lipopolysaccharide-induced BV2 microglial cells via inhibition of NF-κB activation.
    Wu Y; Zhong L; Yu Z; Qi J
    Drug Dev Res; 2019 Mar; 80(2):262-268. PubMed ID: 30724376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
    Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia Mediated Neuroinflammation in Parkinson's Disease.
    Isik S; Yeman Kiyak B; Akbayir R; Seyhali R; Arpaci T
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.